Cancer Drugs | Online pharmaceuticals | Treatment for Cancer

EVERGRAF 0.5MG EVERGRAF 0.5MG belongs to the anti-neoplastic agent; it comes under mTOR kinase inhibitor (single transduction inhibitor). EVERGRAF 0.5MG is an immunosuppressive macrolide. USED FOR Breast cancer  the patient who fails to respond to the tablet letrozole or anastrozole therapy would be treated with Rapact. EVERGRAF 0.5MG is used in an advanced stage of breast cancer. Neuroendocrine tumors  EVERGRAF 0.5MG involved in the treatment of some neuroendocrine tumors like pancreatic, gastrointestinal or lung cancer. Renal cell cancer  patient treating with EVERGRAF 0.5MG after the failure of treatment with Sunitinib or Sorafenib. EVERGRAF 0.5MG also used in the condition of; Heart, liver, kidney transplantation Waldenström macroglobulinemia Other carcinoid tumors. MECHANISM OF ACTION Evergraf is the prohibition of mammalian target of rapamycin (mTOR), a serine-threonine kinase. Evergraf bind with intercellular protein (FKBP-12), leads to inhibitory compl

EVERGRAF 0.25MG Evergraf 0.25mg belongs to the anti-neoplastic agent; it comes under mTOR kinase inhibitor (single transduction inhibitor). Evergraf 0.25mg is an immunosuppressive macrolide. USED FOR Breast cancer  Patient who fails to respond to the tablet letrozole or anastrozole therapy would be treated with Rapact. Evergraf 0.25mg is used in an advanced stage of breast cancer. Neuroendocrine tumors  Evergraf 0.25mg involved in the treatment of some neuroendocrine tumors like pancreatic, gastrointestinal or lung cancer. Renal cell cancer  Patient treating with Evergraf 0.25mg after the failure of treatment with Sunitinib or Sorafenib. Evergraf 0.25mg also used in the condition of; Heart, liver, kidney transplantation Waldenström macroglobulinemia Other carcinoid tumors. MECHANISM OF ACTION Evergraf is the prohibition of mammalian target of rapamycin (mTOR), a serine-threonine kinase. Evergraf bind with intercellular protein (FKBP-12), leads to inhibitory comp

EVERTOR 5MG Evertor 5mg belongs to the anti-neoplastic agent; it comes under mTOR kinase inhibitor (single transduction inhibitor). Evertor 5mg is an immunosuppressive macrolide. EVERTOR USED FOR Breast cancer  The patient who failed to respond to the tablet letrozole or anastrozole therapy, would be treated with Evertor. Evertor 5mg is used in an advanced stage of breast cancer. Neuroendocrine tumors  Evertor 5mg involved in the treatment of some neuroendocrine tumors like pancreatic, gastrointestinal or lung cancer. Renal cell cancer  patient treating with Evertor 5mg after the failure of treatment with Sunitinib or Sorafenib. Evertor also used in the condition of: Heart, liver, kidney transplantation Waldenstrom macroglobulinemia Other carcinoid tumors MECHANISM OF ACTION Evertor is prohibitor of mammalian target of rapamycin (mTOR), a serine threonine kinase. Evertor bind with intercellular protein (FKBP-12), leads to inhibitory complex formation with mTOR comple

EVERTOR 10MG Evertor 10mg belongs to the anti-neoplastic agent; it comes under mTOR kinase inhibitor (single transduction inhibitor). Evertor is an immunosuppressive macrolide. EVERTOR USED FOR Breast cancer Patient who fails to respond to the tablet letrozole or anastrozole therapy would be treated with Evertor. Evertor is used in an advanced stage of breast cancer. Neuroendocrine tumors Evertor involved in the treatment of some neuroendocrine tumors like pancreatic, gastrointestinal or lung cancer. Renal cell cancer Patient treating with Evertor after the failure of treatment with Sunitinib or Sorafenib. Evertor also used in the condition of Heart, liver, kidney transplantation, Waldenstrom macroglobulinemia, Other carcinoid tumors MECHANISM OF ACTION Evertor 10mg is a prohibition of mammalian target of rapamycin (mTOR), a serine-threonine kinase. Evertor bind with intercellular protein (FKBP-12), leads to inhibitory complex formation with mTOR complex 1 (mTORC1)

REVOLADE 25MG Eltrombopag under the brand-name drug Revolade 25mg. The drug is not available as a generic drug. Revolade 25mg drug may be needed as part of combination therapy. Thereby drug may need to take it with other medications. Revolade 25mg is a prescription drug which is used under the guidance of the doctor INDICATION Revolade 25mg is mainly indicated for the treatment of patients having Reduced platelet levels due to chronic immune thrombocytopenia Revolade 25mg is mainly indicated for the treatment of patients having reduced platelet counts due to chronic hepatitis C virus infection Revolade 25mg is mainly indicated for the treatment of patients having Severe Aplastic Anemia 1. First line treatment of severe Aplastic Anemia 2. Treatment of refractory severe Aplastic Anemia MECHANISM OF ACTION Revolade exists in a class of drugs called thrombopoietin (TPO) receptor agonists. Classification of drugs is an association of medications which work in a similar way.

OPDYTA 100MG Opdyta 100mg belongs to a group of cancer drugs known as monoclonal antibodies. Opdyta 100mg is also known as an immune checkpoint inhibitor. Sometimes these drugs are called targeted therapies because they target specific proteins (receptors) on the surface of cells. Opdyta 100mg is a prescription drug which is used under the supervision of a doctor. INDICATION Opdyta 100mg is indicated for the treatment of patients having Melanoma. Opdyta 100mg is indicated for the treatment of patients having Non-Small Cell Lung Cancer. Opdyta 100mg is indicated for the treatment of patients having Kidney (Renal Cell) Cancer. MECHANISM OF ACTION Opdyta prohibits the molecule activity called PD-1, and it is a protein which prevents T cells from recognizing and attacking inflamed tissues and cancer cells. PD-1 can deceit the immune system into overlooking melanoma cells as normal cells. DOSAGE AND ADMINISTRATION Opdyta recommended dosage for unresectable or metastatic melano

OPDYTA 40MG Opdyta 40mg belongs to a group of cancer drugs known as monoclonal antibodies. Opdyta 40mgis also known as an immune checkpoint inhibitor. Sometimes these drugs are called targeted therapies because they target specific proteins (receptors) on the surface of cells. Opdyta 40mg is a prescription drug which is used under the supervision of a doctor. INDICATION Opdyta 40mg is indicated for the treatment of patients having Melanoma. Opdyta 40mg is indicated for the treatment of patients having Non-Small Cell Lung Cancer. Opdyta 40mg is indicated for the treatment of patients having Kidney (Renal Cell) Cancer. MECHANISM OF ACTION Opdyta prohibits the molecule activity called PD-1, and it is a protein which prevents T cells from recognizing and attacking inflamed tissues and cancer cells. PD-1 can deceit the immune system into overlooking melanoma cells as normal cells. DOSAGE AND ADMINISTRATION Opdyta recommended dosage for unresectable or metastatic melanoma : As

NIVOLUMAB Nivolumab belongs to a group of cancer drugs known as monoclonal antibodies. Nivolumab is also known as an immune checkpoint inhibitor. Sometimes these drugs are called targeted therapies because they target specific proteins (receptors) on the surface of cells. Nivolumab is a prescription drug which is used under the supervision of a doctor INDICATION Nivolumab is indicated for the treatment of patients having Melanoma. Nivolumab is indicated for the treatment of patients having Non-Small Cell Lung Cancer. Nivolumab is indicated for the treatment of patients having Kidney (Renal Cell) Cancer. MECHANISM OF ACTION Nivolumab prohibits the molecule activity called PD-1, and it is a protein which prevents T cells from recognizing and attacking inflamed tissues and cancer cells. PD-1 can deceit the immune system into overlooking melanoma cells as normal cells. DOSAGE AND ADMINISTRATION Nivolumab recommended dosage for unresectable or metastatic melanoma : As a single

CABOZANTINIB It belongs to the targeted therapy drug used to cure medullary thyroid cancer and kidney cancer that has spread.  Cabozantinib label includes a black box warning of gastrointestinal perforations, fistulas, and haemorrhage. Cabozantinib is a prescription drug which is used under the supervision of doctors INDICATION Cabozantinib is indicated for the treatment of metastatic medullary thyroid cancer and for the treatment of patients having advanced renal cell carcinoma (RCC) who have to get before anti-angiogenic therapy. MECHANISM OF ACTION Cabozantinib belongs to a type of targeted therapy drug known as a tyrosine kinase inhibitor. It acts by inhibiting the signals inner cancer cells which made them grow and divide. This may help to block or reduced the growth of cancer. It can also prohibit new blood vessels growing in cancer. Cancer cells require to make new blood vessels so they can develop and spread. DOSAGE AND ADMINISTRATION The prescribed dose of Cabozant

ELTROMBOPAG Eltrombopag drug may be needed as part of combination therapy. Thereby drug may need to take it with other medications. Eltrombopag is a prescription drug which is used under the guidance of the doctor INDICATION Eltrombopag is mainly indicated for the treatment of patients having Reduced platelet levels due to chronic immune thrombocytopenia Eltrombopag is mainly indicated for the treatment of patients having reduced platelet counts due to chronic hepatitis C virus infection Eltrombopag is mainly indicated for the treatment of patients having Severe Aplastic Anemia 1. First line treatment of severe Aplastic Anemia 2. Treatment of refractory severe Aplastic Anemia MECHANISM OF ACTION Eltrombopag exist in a class of drugs called thrombopoietin (TPO) receptor agonists. Classification of drugs is an association of medications which work in a similar way. These drugs are often used to treat similar conditions. DOSAGE AND ADMINISTRATION Chronic Hepatitis C-ass